Get started
Author

Alla Yu. Savchenko

Observed names: A. Y. Savchenko, A. Yu. Savchenko, A. Yu. Sаvchenko, A.Y. Savchenko, Alla Savchenko, Alla Y. Savchenko, А. Yu. Savchenko
ORCID: 0000-0003-2734-5036
Observed ORCID: 0000-0003-2734-5036
OpenAlex ID: A5034249553
Mitochondrial-Targeted Plastoquinone Derivatives. Effect on Senescence and Acute Age-Related Pathologies
2011 · M. V. Skulachev, Y. N. Antonenko, et al. · Current Drug Targets · 156
Results of a Multicenter, Randomized, Double-Masked, Placebo-Controlled Clinical Study of the Efficacy and Safety of Visomitin Eye Drops in Patients with Dry Eye Syndrome
2015 · Vladimir V. Brzheskiy, Elena L. Efimova, et al. · Advances in Therapy · 102
PDF
Advances in Development of Rechargeable Mitochondrial Antioxidants
2014 · Alexander N. Lukashev, Maxim V. Skulachev, et al. · Progress in molecular biology and translational science · 24
The dissolution test in biorelevant media as a prognostic tool for modeling of drug behavior in vivo
2011 · G.V. Ramenskaya, I.E. Shohin, et al. · Biomeditsinskaya Khimiya · 11
PDF
The Development of New Factor Xa Inhibitors Based on Amide Synthesis
2018 · Dmitry N. Tarasov, Dmitry G. Tovbin, et al. · Current Drug Discovery Technologies · 5
PDF
Development and Validation of the ELISA Method for Anti-trastuzumab Antibodies Determination in Human Serum
2022 · O. A. Eliseeva, M. A. Kolganova, et al. · Drug development & registration · 3
PDF
Mitochondrial Targeting of Antioxidants
2014 · R. A. Zinovkin, L. E. Bakeeva, et al. · Springer eBooks · 3
Developing In Vitro-In Vivo Correlation (Ivivc) For Trimetazidine, Indapamide And Ciprofloxacin Extended-Release Solid Oral Dosage Forms
2011 · I. E. Shohin, A. Yu. Sаvchenko · International Journal of Pharma and Bio Sciences · 3
Comprehensive Assessment of the Safety of a New Antituberculosis Drug from the Diarylquinolines Group
2021 · A. Yu. Savchenko, G. V. Ramenskaya, et al. · Journal Biomed · 2
PDF
Development and Validation of Tranexamic Acid Determination in Human Plasma by HPLC-MS/MS method
2021 · A. V. Aleshina, T. N. Komarov, et al. · Drug development & registration · 2
Anti-tuberculosis activity in the presence of drug resistance as a rationale for prospect use of thiosonide
2020 · A. Yu. Savchenko, M. S. Burenkov, et al. · Сибирский журнал клинической и экспериментальной медицины · 2
Pharmacokinetic Studies of the Innovative Antituberculosis Drug Thiozonide in Plasma
2015 · A. Yu. Savchenko, L. A. Men’shikova, et al. · Pharmaceutical Chemistry Journal · 2
Pheno- and Genotyping the Prescription of Drugs Metabolized by CYP2D6
2002 · G. V. Ramenskaya, A. Yu. Savchenko, et al. · Bulletin of Experimental Biology and Medicine · 2
Application of in vitro studies to predict the pharmacokinetics of rivaroxaban tablets
2024 · A. V. Suvorova, P. A. Losenkova, et al. · Drug development & registration · 1
PDF
A Study of Embryotoxic, Foetotoxic, and Teratogenic Effects of the Original Antituberculosis Agent Thiozonide in Pregnant Rabbits
2023 · A. Yu. Borodina, K. L. Kryshen, et al. · Safety and Risk of Pharmacotherapy · 1
PDF
Hygienic Monitoring of Working Area Air Pollution by Particulate Matter of ticagrelator in the Pharmaceutical Factory
2022 · I. A. Pozharnov, A. S. Simakov, et al. · Drug development & registration · 1
PDF
Safety assessment of a new anti-tuberculosis drug in silico and with the participation of healthy volunteers
2022 · A. Yu. Savchenko, G. V. Ramenskaya, et al. · Pharmacogenetics and Pharmacogenomics · 1
PDF
Study of Genotoxic Properties of Thiosonide
2021 · A. Yu. Sаvchenko, M. S. Burenkov, et al. · Tuberculosis and lung diseases · 1
PDF
Development and Validation of a Method for Assay of the Original Antituberculosis Agent Thiozonide in Plasma for Pharmacokinetic Studies
2015 · G. V. Ramenskaya, I. E. Shokhin, et al. · Pharmaceutical Chemistry Journal · 1
Dissolution kinetics of low-soluble drug (nifedipine) in biorelevant media
2011 · E. A. Volkova, I. E. Shohin, et al. · Биофармацевтический журнал · 1
Oligonucleotide Adjuvants in Vaccinology: Current Classification, Mechanisms of Action, and Development Trends
2026 · Olga V. Kraineva, Nadezhda A. Besedina, et al. · Medicine and Biotechnology
PDF
Current approaches to paclitaxel formulation development: challenges and future perspectives (review)
2026 · A. S. Barazova, S. V. Ovsienko, et al. · Drug development & registration
Mathematical pharmacokinetics modeling of parenteral depot formulations
2026 · L. A. Murtazalieva, A. Yu. Savchenko, et al. · Drug development & registration
PDF
Evaluation of Safety of Thiosonide in Multiple Doses in Patients with Multidrug, Pre-extensively or Extensively Drug-Resistant Pulmonary Tuberculosis: a Multicenter Randomized Controlled Study
2025 · A. Yu. Savchenko, M. S. Burenkov, et al. · Tuberculosis and lung diseases
PDF
Development and validation of esomeprazole magnesium trihydrate determination in workplace air using HPLC-MS/MS
2025 · A. Yu. Savchenko, P. A. Zhiltcov, et al. · Drug development & registration
PDF
Works count: 42
Citation count: 324
H-index: 5
I10-index: 4
Year
Topic
Type